Literature DB >> 11525844

Synthesis and antidepressant activities of some 3,5-diphenyl-2-pyrazolines.

E Palaska1, M Aytemir, I T Uzbay, D Erol.   

Abstract

Ten new 3,5-diphenyl-2-pyrazoline derivatives were synthesised by reacting 1,3-diphenyl-2-propen-1-one with hydrazine hydrate. The chemical structures of the compounds were proved by means of their IR, 1H-NMR spectroscopic data and microanalyses. The antidepressant activities of these compounds were evaluated by the 'Porsolt Behavioural Despair Test' on Swiss-Webster mice. 3-(4-Methoxyphenyl)-5-(3,4-dimethoxyphenyl)-2-pyrazoline, 3-(4-methoxyphenyl)-5-(2-chloro-3,4-dimethoxyphenyl)-2-pyrazoline and 3-(4-chlorophenyl)-5-(2-chloro-3,4-dimethoxyphenyl)-2-pyrazoline reduced 41.94-48.62% immobility times at 100 mgkg(-1) dose level. In addition, it was found that 4-methoxy and 4-chloro substituents on the phenyl ring at position 3 of the pyrazoline ring increased the antidepressant activity; the replacement of these groups by bromo and methyl substituents decreased activity in mice.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11525844     DOI: 10.1016/s0223-5234(01)01243-0

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  19 in total

1.  Synthesis, characterization and antimicrobial activity of certain novel aryl hydrazone pyrazoline-5-ones containing thiazole moiety.

Authors:  Maliki Reddy Dastagiri Reddy; Aluru Raghavendra Guru Prasad; Yadati Narasimha Spoorthy; Lakshmana Rao Krishna Rao Ravindranath
Journal:  Adv Pharm Bull       Date:  2013-02-07

2.  An efficient and green reaction of isatins, 3-amino-1-phenyl-2-pyrazolin-5-one (3-amine-1H-pyrazole), and β-diketone in aqueous medium.

Authors:  Zhansheng Wang; Hui Xu; Lirong Yan; Qingyang Li; Liangce Rong
Journal:  Mol Divers       Date:  2017-08-21       Impact factor: 2.943

3.  A novel pseudo six-component synthesis of functionalized pyrazoles in ethanol by cascade reaction.

Authors:  Atieh Rezvanian; Maedeh Babashah; Maryam Anafcheh
Journal:  Mol Divers       Date:  2019-01-11       Impact factor: 2.943

4.  Evaluation of selective human MAO inhibitory activities of some novel pyrazoline derivatives.

Authors:  Umut Salgin-Gökşen; Samiye Yabanoğlu-Çiftçi; Ayşe Ercan; Kemal Yelekçi; Gülberk Uçar; Nesrin Gökhan-Kelekçi
Journal:  J Neural Transm (Vienna)       Date:  2013-01-30       Impact factor: 3.575

5.  Eco-friendly synthesis and antimicrobial activities of some 1-phenyl-3(5-bromothiophen-2-yl)-5-(substituted phenyl)-2-pyrazolines.

Authors:  Ramalingam Sasikala; Kannan Thirumurthy; Perumal Mayavel; Ganesamoorthy Thirunarayanan
Journal:  Org Med Chem Lett       Date:  2012-06-11

6.  Antidepressant potential of nitrogen-containing heterocyclic moieties: An updated review.

Authors:  Nadeem Siddiqui; Sandhya Bawa; Ruhi Ali; Obaid Afzal; M Jawaid Akhtar; Bishmillah Azad; Rajiv Kumar
Journal:  J Pharm Bioallied Sci       Date:  2011-04

7.  Synthesis, preclinical evaluation and antidepressant activity of 5-substituted phenyl-3-(thiophen-2-yl)-4, 5-dihydro-1H-pyrazole-1-carbothioamides.

Authors:  Bijo Mathew; Jerad Suresh; S Anbazhagan
Journal:  EXCLI J       Date:  2014-04-29       Impact factor: 4.068

8.  Novel 3,4-Methylenedioxybenzene Scaffold Incorporated 1,3,5-Trisubstituted-2-pyrazolines: Synthesis, Characterization and Evaluation for Chemotherapeutic Activity.

Authors:  S R Deshpande; S N Nagrale; M V Patil; P S Chavan
Journal:  Indian J Pharm Sci       Date:  2015 Jan-Feb       Impact factor: 0.975

9.  Crystal structure of 3-methyl-1-phenyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-4-carbaldehyde.

Authors:  Joel T Mague; Shaaban K Mohamed; Mehmet Akkurt; Talaat I El-Emary; Mustafa R Albayati
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-09-27

10.  N1-benzenesulfonyl-2-pyrazoline hybrids in neurological disorders: Syntheses, biological screening and computational studies.

Authors:  Avinash C Tripathi; Savita Upadhyay; Sarvesh Paliwal; Shailendra K Saraf
Journal:  EXCLI J       Date:  2018-01-19       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.